What is Pharmunion?
PharmUnion LLC, established in 2006 and based in Wilmington, Delaware, is dedicated to the research, development, production, and marketing of a wide array of health products. Its portfolio spans dietary supplements and medical devices, addressing critical areas such as gastroenterology, urology, pediatrics, and respiratory health. The company's commitment to quality and innovation has been recognized with the International Quality Award in the Platinum Category. Operating from FDA-certified manufacturing facilities, PharmUnion holds patents and trademarks for its proprietary offerings, facilitating international sales and underscoring its global market presence.
How much funding has Pharmunion raised?
Pharmunion has raised a total of $10K across 1 funding round:
Debt
$10K
Debt (2021): $10K with participation from PPP
What's next for Pharmunion?
As Pharmunion navigates its Series A/B growth stage, the recent influx of moderate growth capital is expected to fuel strategic advancements. This investment will likely support enhanced research and development efforts, expansion of manufacturing capabilities, and broader market outreach for its innovative health products. The company's focus on patented technologies and international sales suggests a strategic direction aimed at solidifying its position as a key player in the global pharmaceutical and health product industry. Future developments may include new product launches and strategic partnerships to accelerate growth.
See full Pharmunion company page
